Skip to main content

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Identificación mediante análisis proteómico del humor vítreo de nuevas dianas terapéuticas en la retinopatía diabética proliferativa y en el edema macular diabético

IP: Rafael Simó Canonge
Collaborators: -
Funding agency: Fundación para la Diabetes
Funding: 39942
Reference: BRM2006-01
Duration: 01/01/2007 - 31/12/2008

Mediadores patogénicos del edema macular diabético: exploración de nuevos candidatos mediante análisis proteómico en humor vítreo y cultivos celulares

IP: Rafael Simó Canonge
Collaborators: -
Funding agency: Novo Nordisk Pharma SA
Funding: 6000
Reference: NORDISK/1/2006
Duration: 30/05/2006 - 31/12/2007

Mediadores patogénicos del edema macular diabético: exploración de nuevos candidatos mediante análisis proteómico en humor vítrico y cultivos celulares

IP: Rafael Simó Canonge
Collaborators: Àlex Fonollosa Calduch, Cristina Hernández Pascual, Monica Higuera Urbano
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 150766
Reference: SAF2006-05284
Duration: 01/10/2006 - 30/09/2009

Ministerio de Ciencia

Mediadors patogènics de l'edema macular diabètic: estudi comparatiu amb la retinopatia diabètica proliferativa i exploració de nous candidats mitjançant anàlisi proteòmica a l'humor vitri

IP: Rafael Simó Canonge
Collaborators: -
Funding agency: Fundació ACMSCB-SC.
Funding: 18000
Reference: ACMCB/2/2006
Duration: 01/05/2006 - 31/12/2007

Related news

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

Related professionals

Pedro Serrano Pérez

Pedro Serrano Pérez

Research technician
Psychiatry, Mental Health and Addictions
Read more
Sergio Lopez Fernandez

Sergio Lopez Fernandez

Predoctoral researcher
Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more
Paula Fernández Álvarez

Paula Fernández Álvarez

Research technician
Genetics Medicine
Read more
Coro Bescós Atin

Coro Bescós Atin

Head of group
New Technologies and Craniofacial Microsurgery
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.